Skip to content

Longevity Drug Index / Metformin

Rank 7 of 10Disappointing

Metformin

The world’s most-used diabetes drug, once the leading longevity hope, which failed in the NIA mouse program.

Rank
7 of 10
Drug class
Biguanide
Approved for
Type 2 diabetes
Also known as
Glucophage

How it works

Metformin mainly lowers the amount of glucose the liver releases into the blood. It acts on mitochondria, the cell’s power plants, and activates AMPK, an energy sensor that switches cells into a conservation mode. It also lowers insulin levels and changes the gut microbiome.

How it could help longevity

Activating AMPK and lowering insulin mimic some effects of eating less. Early observational studies suggested people with diabetes taking metformin lived as long as people without diabetes, which led to the proposed TAME trial of metformin for aging.

Animal studies

  • Early mouse study, 2013A small study in one mouse strain found low-dose metformin extended lifespan by about 6%, while a higher dose shortened it.
  • NIA Interventions Testing Program, 2016In the more rigorous multi-site test, metformin alone did not extend lifespan. Combined with rapamycin, it worked about as well as rapamycin alone.
  • WormsMetformin extended lifespan in worms, partly through effects on their gut bacteria.

Human studies

  • Observational data, 2014A large UK study suggested metformin users with diabetes had similar survival to people without diabetes, but later analyses found this was likely affected by bias.
  • Exercise trials, 2019In older adults, metformin blunted muscle growth from strength training and reduced fitness gains from aerobic exercise.
  • TAME trialA large trial of metformin to delay age-related disease has been planned for years but has struggled to secure full funding.

Safety and side effects

Stomach upset and diarrhoea are common at first. Long-term use can lower vitamin B12. Lactic acidosis is rare and mainly a risk with poor kidney function. It can interfere with the benefits of exercise.

Our view

Excellent for type 2 diabetes, but the case for using it to slow aging in healthy people has weakened. Failing in the NIA program and blunting exercise gains are major strikes against it.

Last reviewed 11 November 2026. General information, not medical advice. None of these drugs is approved to slow aging.